Dimensional Fund Advisors LP Akebia Therapeutics, Inc. Transaction History
Dimensional Fund Advisors LP
- $418 Billion
- Q2 2025
A detailed history of Dimensional Fund Advisors LP transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 882,101 shares of AKBA stock, worth $2.43 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
882,101
Previous 535,431
64.75%
Holding current value
$2.43 Million
Previous $1.03 Million
212.26%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AKBA
# of Institutions
170Shares Held
106MCall Options Held
134KPut Options Held
262K-
Vanguard Group Inc Valley Forge, PA14.6MShares$40.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$32 Million0.0% of portfolio
-
State Street Corp Boston, MA8MShares$22 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.07MShares$16.7 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$15.8 Million20.26% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $506M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...